Mallamaci, Francesca
 Distribuzione geografica
Continente #
AS - Asia 3.596
NA - Nord America 1.865
EU - Europa 972
SA - Sud America 709
Continente sconosciuto - Info sul continente non disponibili 357
AF - Africa 71
OC - Oceania 6
Totale 7.576
Nazione #
US - Stati Uniti d'America 1.734
SG - Singapore 1.503
CN - Cina 793
BR - Brasile 565
IT - Italia 407
VN - Vietnam 349
HK - Hong Kong 344
FR - Francia 204
BD - Bangladesh 201
KR - Corea 129
JP - Giappone 75
GB - Regno Unito 58
DE - Germania 57
CA - Canada 54
FI - Finlandia 53
AR - Argentina 52
IN - India 49
NL - Olanda 43
EC - Ecuador 26
MX - Messico 25
ID - Indonesia 24
ZA - Sudafrica 20
IL - Israele 19
CO - Colombia 18
IQ - Iraq 17
UA - Ucraina 17
ES - Italia 16
MA - Marocco 16
IE - Irlanda 15
RU - Federazione Russa 15
PL - Polonia 13
AT - Austria 12
JM - Giamaica 11
PY - Paraguay 11
SA - Arabia Saudita 11
TR - Turchia 11
UY - Uruguay 11
VE - Venezuela 11
CR - Costa Rica 10
PK - Pakistan 9
SE - Svezia 9
AE - Emirati Arabi Uniti 7
EG - Egitto 7
PE - Perù 7
TT - Trinidad e Tobago 7
AL - Albania 6
KG - Kirghizistan 6
MY - Malesia 6
NI - Nicaragua 6
UZ - Uzbekistan 6
BO - Bolivia 5
DZ - Algeria 5
HU - Ungheria 5
JO - Giordania 5
LT - Lituania 5
NP - Nepal 5
TN - Tunisia 5
AZ - Azerbaigian 4
GR - Grecia 4
GT - Guatemala 4
HN - Honduras 4
HR - Croazia 4
AU - Australia 3
CH - Svizzera 3
CL - Cile 3
CZ - Repubblica Ceca 3
KE - Kenya 3
NZ - Nuova Zelanda 3
RO - Romania 3
RS - Serbia 3
TH - Thailandia 3
AO - Angola 2
BY - Bielorussia 2
DJ - Gibuti 2
EE - Estonia 2
KZ - Kazakistan 2
LB - Libano 2
LC - Santa Lucia 2
MT - Malta 2
PA - Panama 2
PH - Filippine 2
PR - Porto Rico 2
SI - Slovenia 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
BB - Barbados 1
BE - Belgio 1
BF - Burkina Faso 1
BG - Bulgaria 1
BH - Bahrain 1
CM - Camerun 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
GH - Ghana 1
HT - Haiti 1
IM - Isola di Man 1
IR - Iran 1
Totale 7.199
Città #
Singapore 938
Santa Clara 423
Hong Kong 340
Hefei 276
San Jose 191
Lauterbourg 166
Beijing 157
Ashburn 141
Seoul 129
Ho Chi Minh City 126
Los Angeles 99
Hanoi 89
New York 70
Dallas 65
Tokyo 50
São Paulo 41
Buffalo 35
Rome 29
Milan 27
Frankfurt am Main 25
Lappeenranta 24
Helsinki 19
Minamishinagawa 18
Rio de Janeiro 16
Council Bluffs 15
Orem 15
Amsterdam 14
Brooklyn 14
Da Nang 14
Dublin 14
Haiphong 14
Chicago 13
Curitiba 13
Naples 13
Bengaluru 12
Warsaw 12
Belo Horizonte 11
Houston 11
London 11
Montreal 11
Bologna 10
Johannesburg 10
Quito 10
Thái Bình 10
Toronto 10
Biên Hòa 9
Brasília 9
Catania 9
Guayaquil 9
Montevideo 9
Portsmouth 9
Turku 9
Denver 8
Düsseldorf 8
Newark 8
Pisa 8
Porto Alegre 8
San José 8
Stockholm 8
Vienna 8
Boston 7
Lima 7
Mexico City 7
Munich 7
Salvador 7
Atlanta 6
Bari 6
Bishkek 6
Campinas 6
Dhaka 6
Guarulhos 6
Kingston 6
Mumbai 6
Phoenix 6
San Francisco 6
Tashkent 6
Turin 6
Amman 5
Baghdad 5
Charlotte 5
City of London 5
Falerna 5
Falkenstein 5
Florianópolis 5
Ha Long 5
Managua 5
Miami 5
Philadelphia 5
Queens 5
The Bronx 5
Baku 4
Baltimore 4
Boardman 4
Bogotá 4
Buenos Aires 4
Campos dos Goytacazes 4
Cape Town 4
Chennai 4
Contagem 4
Gardena 4
Totale 4.090
Nome #
8-hydroxy-2′-deoxyguanosine, a biomarker of oxidative DNA injury, in diabetic kidney disease 125
Inflammation is an amplifier of lung congestion by high lv filling pressure in hemodialysis patients: a longitudinal study 106
The long-term effect of a lung-ultrasound intervention on the risk for death, heart failure and myocardial infarction in dialysis patients 96
Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) update 91
Sleep apnoea syndrome prevalence in chronic kidney disease and end-stage kidney disease patients: a systematic review and meta-analysis 91
Can the assessment of ultrasound lung water in haemodialysis patients be simplified? 91
Antihypertensive Drug Treatment and the Risk for Intrahemodialysis Hypotension 87
Epidemiology of hyperkalemia in CKD patients under nephrological care: a longitudinal study 87
Socioeconomic Status and Clinical Outcomes in Chronic Kidney Disease: Bootstrap Validation of a Simple Indicator 87
Osteopontin, death and cardiovascular events in stage G3–4 CKD patients: a joint model analysis 84
Treatment-resistant hypertension in the hemodialysis population: a 44-h ambulatory blood pressure monitoring-based study 84
Neuropeptide y gene polymorphisms and chronic kidney disease progression 79
Proprotein convertase subtilisin/kexin type 9 (PCSK9) and clinical outcomes in dialysis patients 79
Role of kidney function on Nrf2 mRNA levels in type 2 diabetes 77
Long-term blood pressure monitoring by office and 24-h ambulatory blood pressure in renal transplant patients: a longitudinal study 74
Comparative effectiveness of different antihypertensive agents in kidney transplantation: a systematic review and meta-analysis 73
Office, standardized and 24-h ambulatory blood pressure and renal function loss in renal transplant patients 73
Sympathetic nerve traffic overactivity in chronic kidney disease: a systematic review and meta-analysis 73
Effect of inflammation by acute sepsis on intact fibroblast growth factor 23 (iFGF23) and asymmetric dimethyl arginine (ADMA) in CKD patients 68
Osteopontin and Clinical Outcomes in Hemodialysis Patients 68
Long-Term Effect of Physical Exercise on the Risk for Hospitalization and Death in Dialysis Patients A Post-Trial Long-Term Observational Study 67
Assessment of hypertension in kidney transplantation by ambulatory blood pressure monitoring: a systematic review and meta-analysis 67
A polymorphism in the major gene regulating serum uric acid associates with clinic SBP and the white-coat effect in a family-based study 66
Inflammation biomarkers and inflammatory genes expression in metabolically healthy obese patients 65
Asymmetric and Symmetric Dimethylarginine and Sympathetic Nerve Traffic after Renal Denervation in Patients with Resistant Hypertension 64
Plasma levels of myeloperoxidase and resistin independently predict mortality in dialysis patients 63
Sleep-Disordered Breathing and 24-Hour Ambulatory Blood Pressure Monitoring in Renal Transplant Patients: Longitudinal Study 63
Pulse Wave Velocity and Prognosis in End-Stage Kidney Disease 62
Nocturnal Hypertension and Altered Night-Day BP Profile and Atherosclerosis in Renal Transplant Patients 62
Physical activity and exercise in chronic kidney disease: consensus statements from the Physical Exercise Working Group of the Italian Society of Nephrology 62
A randomized multicenter trial on a lung ultrasound-guided treatment strategy in patients on chronic hemodialysis with high cardiovascular risk 62
A Genetic Marker of Uric Acid Level, Carotid Atherosclerosis, and Arterial Stiffness: A Family-Based Study 61
Phosphate and the renoprotective effect of ace inhibition: a post-hoc analysis of the Rein Trial. 60
Reducing salt intake by urine chloride self-measurement in non-compliant patients with chronic kidney disease followed in nephrology clinics: a randomized trial 60
Hyperhomocysteinemia and arteriovenous fistula thrombosis in hemodialysis patients 60
The dominant prognostic value of physical functioning among quality of life domains in end-stage kidney disease 60
Hypertension in kidney transplantation: a consensus statement of the ‘hypertension and the kidney’ working group of the European Society of Hypertension 58
Venous bicarbonate and CKD progression: a longitudinal analysis by the group-based trajectory model 58
The bidirectional link between left ventricular hypertrophy and chronic kidney disease. A cross lagged analysis 58
The sirtuinl gene associates with left ventricular myocardial hypertrophy and remodeling in two chronic kidney disease cohorts: a longitudinal study 58
Are there sex differences in cardiovascular outcomes in non-dialysis CKD patients? 58
Long-Term Changes in Sleep Disordered Breathing in Renal Transplant Patients: Relevance of the BMI 57
Effect of a home based, low intensity, physical exercise program in older adults dialysis patients: a secondary analysis of the EXCITE trial 56
CKD-MBD biomarkers and CKD progression: an analysis by the joint model 56
Salt intake correlates with night systolic blood pressure in non-dialytic chronic kidney disease 53
Adiponectin and Leptin in chronic kidney disease: causal factors or mere risk markers? 52
Quality of life and kidney function in CKD patients: a longitudinal study 52
Tissue inhibitor of metalloproteinases (TIMP-1), genetic markers of insulin resistance and cardiomyopathy in patients with kidney failure 52
Association of IL-6 and a functional polymorphism in the IL-6 gene with cardiovascular events in patients with CKD 52
Shedding a light on sex disparity in clinical trials in CKD patients 51
Serum Erythroferrone Levels Associate with Mortality and Cardiovascular Events in Hemodialysis and in CKD Patients: A Two Cohorts Study 51
Blood pressure monitoring in kidney transplantation: a systematic review on hypertension and target organ damage 51
Valore prognostico delle formule di dtims del FG nella popolazione di pazienti con MRC dello studio MAURO. 50
Synergism between asymmetric dimethylarginine (ADMA) and a genetic marker of uric acid in CKD progression 50
Hypertension management in chronic kidney disease 50
Biomarkers in clinical epidemiology studies 50
Intact FGF23 and ?-klotho during acute inflammation/sepsis in CKD patients 50
Reclassification of chronic kidney disease patients for end-stage renal disease risk by proteinuria indexed to estimated glomerular filtration rate: multicentre prospective study in nephrology clinics 50
A polymorphismin a major antioxidant gene (Kelch-like ECH-associated protein1) predicts incident cardiovascular events in chronic kidney disease patients: an exploratory study 49
FGF23 and the PTH response to paricalcitol in chronic kidney disease 49
Sympathetic neural overdrive in congestive heart failure and its correlates: systematic reviews and meta-analysis 48
Prognostic values of left ventricular mass index in chronic kidney disease patients 48
Rationale and Protocol of the ETERNITY-ITA Study: Use of Etelcalcetide for Preserving Vitamin K-Dependent Protein Activity-An Italian Study 48
Inflammation downregulates FGF23 in chronic kidney disease (CKD) patients. 47
Endogenous opioid antagonism and the insulin response to oral glucose load in kidney failure patients: a randomized clinical trial 47
Fluid overload trajectories and mortality in hemodialysis patients 46
Physical activity in chronic kidney disease and the EXerCise Introduction To Enhance trial 45
Detection of pulmonary congestion by chest ultrasound (US) in dialysis patients. 44
Vitamin D receptor activation raises soluble thrombomodulin levels in chronic kidney disease patients: a double blind, randomized trial 44
Decoy receptors as biomarkers for exploring aetiology and designing new therapies 44
Neuropeptide Y receptor Y2 gene polymorphism interacts with plasma neuropeptide Y levels in predicting left ventricular hypertrophy in dialysis patients 43
Atherosclerosis and the Glu298Asp polymorphism of the eNOS gene in white patients with end stage renal disease. 43
Resistin and all-cause and cardiovascular mortality: Effect modification by adiponectin in end-stage kidney disease patients 43
Neuropeptide Y and chronic kidney disease progression: a cohort study 43
Obesity and the epidemiology and prevention of kidney disease: waist circumference versus body mass index. 42
Risk Factors of Chronic Kidney Disease Progression: Between Old and New Concepts 42
eNOS and Caveolin-1 Gene Polymorphisms Interaction and Intima Media Thickness: A Proof of Concept Study in ESRD Patients. 40
Plasma cytokines, glomerular filtration rate and adipose tissue cytokines gene expression in chronic kidney disease (CKD) patients. 40
Effectiveness of cold HD for the prevention of HD hypotension and mortality in the general HD population 39
Long term predictors of cerebrovascular events in patients with end stage renal disease (ESRD). 38
Association of a polymorphism in a gene encoding a urate transporter with ckd progression 38
Circulating soluble receptor for advanced glycation end product (sRAGE) and left ventricular hypertrophy in patients with chronic kidney disease (CKD) 38
I polimorfismi del gene ENPP1 si associano ad ipertrofia ventricolare sinistra ed alla funzione sistolica nei pazienti in dialisi. 37
Lung ultrasound to detect and monitor pulmonary congestion in patients with acute kidney injury in nephrology wards: a pilot study 36
EARLY MORNING HEMODYNAMIC CHANGES AND LEFT VENTRICULAR HYPERTROPHY AND MORTALITY IN HEMODIALYSIS PATIENTS 36
The legacy effect of a home walking exercise programme in kidney failure patients on dialysis 36
Joint effect of insulin signaling genes on all-cause mortality 35
The E-selectin gene polymorphism and carotid atherosclerosis in end-stage renal disease. 34
Fitness for Entering a Simple Exercise Program and Mortality: A Study Corollary to the Exercise Introduction to Enhance Performance in Dialysis (Excite) Trial 34
Vitamin D Receptor (VDR) gene polymorphism is associated with Left Ventricular (LV) mass and predicts Left Ventricular Hypertrophy (LVH) progression in End-Stage Renal Disease (ESRD) patients 34
The fat-mass and obesity-associated gene (FTO) predicts mortality in chronic kidney disease of various severity 33
High estimated pulmonary artery systolic pressure predicts adverse cardiovascular outcomes in stage 2-4 chronic kidney disease 33
Biomarkers of left atrial volume: a longitudinal study in patients with end stage renal disease. 32
Il polimorfismo T585C del gene del recettore Y2 del Neuropeptide Y (NPY2R) interagisce con i livelli plasmatici di NPY nel predire l'ipertrofia ventricolare sinistra (IVS) nei pazienti in dialisi. 32
Comment accompanying: Obstructive sleep apnoea: A stand-alone risk factor for chronic kidney disease by Chou Yu-Ting 32
Neuropeptide Y predicts cardiovascular events in chronic kidney disease patients: a cohort study. 32
Sympathetic Nerve Traffic Activation in Essential Hypertension and Its Correlates: Systematic Reviews and Meta-Analyses 32
ENPP1 Gene Polymorphisms are associated with left ventricular (LV) mass and systolic function in end stage renal disease (ESRD) patients. 32
Vitamin K In PEritonial DIAlysis (VIKIPEDIA): Rationale and study protocol for a randomized controlled trial 31
FGF23 beyond bone mineral metabolism: functional relationship with inflammation in chronic kidney disease patients. 31
Totale 5.520
Categoria #
all - tutte 26.898
article - articoli 19.548
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 504
Totale 46.950


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202496 0 0 0 0 0 0 0 0 56 15 24 1
2024/20252.782 18 15 213 192 537 58 110 208 99 86 702 544
2025/20264.430 233 423 405 554 765 132 635 253 231 300 271 228
2026/2027268 268 0 0 0 0 0 0 0 0 0 0 0
Totale 7.576